Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma

4 Feb 2009

Abstract excerpt

PURPOSE: Reliable data on the persistence of tumor expression of cancer-testis (CT) antigens over time and consequent analyses of the effect of CT antigen expression on the clinical course of malignancies are crucial for their evaluation as diagnostic markers and immunotherapeutic targets. EXPERIMENTAL DESIGN: Applying conventional reverse transcription-PCR, real-time PCR, and Western blot, we did the first...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy and Immune Responses
Share to Multiple Myeloma Research and Treatments
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19190130
DOI: 10.1158/1078-0432.ccr-08-0989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple MyelomaPMID 19190130Read ↗

The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patientsSemantic proximity Read ↗

MAGE‐C1/CT‐7 expression in plasma cell myeloma: Sub‐cellular localization impacts on clinical outcomeSemantic proximity Read ↗

CD8+T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burdenSemantic proximity Read ↗

Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.Semantic proximity Read ↗

Sperm protein 17 is a novel cancer-testis antigen in multiple myelomaSemantic proximity Read ↗

Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.Semantic proximity Read ↗

Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Semantic proximity Read ↗

Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen‐specific cellular immunitySemantic proximity Read ↗

Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients.Semantic proximity Read ↗

Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapySemantic proximity Read ↗

Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancerSemantic proximity Read ↗

T-cell antigen-positive multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.